Skip to main content

Table 2  CRC incidence and all-cause mortality in patients with 3–4 MetS components versus 1–2 MetS components

From: Association between metabolic syndrome and colorectal cancer incidence and all-cause mortality: a hospital-based observational study

Outcomes

No.

Events

Follow-up duration (years)a

Event Rate

(/100,000 Person-Years)

Crude

HR (95% CI)

P-value

CRC

      

  1–2 components

78,274

792

4.39 (2.61–6.29)

223.09

Reference

< 0.001

  3–4 components

41,569

526

4.35 (2.62–6.23)

280.85

1.26 (1.13–1.41)

All-cause mortality

      

  1–2 components

78,274

6,781

4.42 (2.64–6.32)

1900.11

Reference

 

  3–4 components

41,569

3,947

4.39 (2.65–6.26)

2094.32

1.10 (1.06–1.15)

< 0.001

All comparisons were based on matched cohorts. Significant values are showing in bold.

a Presented in medium (Q1-Q3).

Abbreviations: CRC, colorectal cancer; HR, hazard ratio.